Christy J. Oliger - 07 Jun 2023 Form 4 Insider Report for REATA PHARMACEUTICALS INC

Role: Director
Signature: /s/ Tracy Herson, attorney-in-fact
Issuer symbol: N/A
Transactions as of: 07 Jun 2023
Net transactions value: +$157,452
Form type: 4
Filing time: 09 Jun 2023, 16:24:22 UTC
Previous filing: 25 May 2023
Next filing: 14 Sep 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RETA	Class A common stock	Award	$157,452	+1,682	+43%	$93.61	5,565	07 Jun 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	RETA	Stock Option (right-to-buy)	Award	$0	+2,137		$0.000000	2,137	07 Jun 2023	Class A common stock	2,137	$93.61	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares represent Restricted Stock Units (RSUs), which vest on June 5, 2024, subject to continued service through the vesting date.
F2	The option vests in 4 equal installments on September 7, 2023, December 7, 2023, March 7, 2024, and June 5, 2024, subject to continued service through each vesting date.